Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013

Eurosurveillance

Volumn 19, Issue 34, 2014, Pages

  Turner, N ^a   Pierse, N ^b   Bissielo, A ^c   Huang, Q S ^c   Radke, S ^a,c   Baker, M G ^b   Widdowson, M A ^d   Kelly, H ^e,f   Adlam, Bruce ^g   Aley, Debbie ^g   Bandaranayake, Don ^g   Cameron, John ^g   Davey, Kirsten ^g   Davies, Gillian ^g   Duque, Jazmin ^g   Els, Leane ^g   Grant, Cameron C ^g   Gordon, Rosemary ^g   Gross, Diane ^g   Howie, Marion ^g   Mackereth, Graham ^g   McArdle, Barbara ^g   McArthur, Colin ^g   Reynolds, Gary ^g   Roberts, Sally ^g   Seeds, Ruth ^g   Taylor, Susan ^g   Thomas, Paul ^g   Thompson, Mark ^g   Trenholme, Adrian ^g   Webby, Richard ^g   Williamson, Deborah A ^g   Wong, Conroy ^g   Wood, Tim ^g   Wong, Sam ^g   more..

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^f VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANTIGENICITY; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; POLYMERASE CHAIN REACTION; PRIMARY HEALTH CARE; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THROAT CULTURE; VERY ELDERLY;

EID: 84906841941     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.34.20884     Document Type: Article

References (20)

1. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378(9807):1917-1930. http://dx.doi.org/10.1016/S0140-6736(11)61051-9.
2. Carrat F, Sahler C, Rogez S, Leruez-Ville M, Freymuth F, Le Gales C, et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med. 2002;162(16):1842-1848. http://dx.doi.org/10.1001/archinte.162.16.1842.
3. Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012;8(7):851-862. http://dx.doi.org/10.4161/hv.19917.
4. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365(9461):773-780. http://dx.doi.org/10.1016/S0140-6736(05)17984-7.
5. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis. 2011;12(1):36-44. http://dx.doi.org/10.1016/S1473-3099(11)70295-X.
6. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(30):3104-3109. http://dx.doi.org/10.1016/j.vaccine.2013.04.026.
7. Statistics New Zealand (NZ). 2013 Census. Wellington: Statistics NZ. [Accessed 28 Aug 2014]. Available from: http://www.stats.govt.nz/Census/2013-census.aspx.
8. World Health Organization (WHO) Regional Office for Europe. WHO Regional Office for Europe guidance for influenza surveillance in humans. Copenhagen: WHO Regional Office for Europe; 2009. [Accessed 16 Mar 2011]. Updated May 2011 document available from: http://www.euro.who.int/__data/assets/pdf_file/0020/90443/E92738.pdf.
9. Suess T, Remschmidt C, Schink SB, Schweiger B, Heider A, Milde J, et al. Comparison of shedding characteristics of seasonal influenza virus (sub) types and influenza A(H1N1)pdm09; Germany, 2007-2011. PloS One. 2012;7(12):e51653. http://dx.doi.org/10.1371/journal.pone.0051653.
10. World Health Organization (WHO). Interim epidemiological surveillance standards for influenza. Geneva: WHO; 2012. [Accessed 4 Sep 2013]. Global epidemiological surveillance standards for influenza, 2013, available from: http://www.who.int/influenza/resources/documents/influenza_surveillance:manual/en/.
11. Crampton P, Salmon C, Kirkpatrick R. Degrees of deprivation in New Zealand: an atlas of socioeconomic difference. 2nd ed. Auckland: David Bateman Ltd; 2004.
12. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437-1440. http://dx.doi.org/10.1136/bmj.306.6890.1437.
13. Shu B, Wu KH, Emery S, Villanueva J, Johnson R, Guthrie E, et al. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A(H1N1) pandemic influenza virus. J Clin Microbiol. 2011;49(7):2614-26149. http://dx.doi.org/10.1128/JCM.02636-10.
14. Szewczuk E, Thapa K, Anninos T, McPhie K, Higgins G, Dwyer DE, et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis., 2010;10:113. http://dx.doi.org/10.1186/1471-2334-10-113.
15. Hunag Q, Baker M, McArthur C, Roberts S, Williamson D, Grant C, et al. Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand. Western Pac Surveill Response J. 2014;5(2):23-30. http://dx.doi.org/10.5365/wpsar.2014.5.1.004.
16. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis. 2011;203(4):500-508. http://dx.doi.org/10.1093/infdis/jiq076.
17. Centers for Disease Control and Prevention (CDC). Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. MMWR Morb Mortal Wkly Rep. 2013. 62(7):119-123.
18. McMenamin J, Andrews N, Robertson C, Fleming D, Durnall H, von Wissmann B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill. 2013;18(5):pii=20393.
19. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PloS One. 2014;9(3):e92153. http://dx.doi.org/10.1371/journal.pone.0092153.
20. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case– control study, influenza season 2012/13. Euro Surveill. 2014;19(6):pii=20701.